Tags

Type your tag names separated by a space and hit enter

Clinical trial with bromelain in third molar exodontia.
Eur Rev Med Pharmacol Sci 2010; 14(9):771-4ER

Abstract

BACKGROUND AND OBJECTIVE

Bromelain is a proteolytic enzyme, particularly effective in the treatment of soft tissue inflammations and traumas, in localized inflammations, especially in presence of hydropsy and also in postoperative tissue reactions. The aim of the present study is to assess the efficacy of bromelain in controlling the edema and its related pain in the inflamed area after upper third molar exodontia.

MATERIALS AND METHODS

The effectiveness of our protocol was evaluated by a clinical assessment of the profile of the hemiface corresponding to the treated area: indeed, the linear values of the trago-pogonion distances were measured. Algogens were determined by VAS (Visual Analogue Scale) (Figure 1) with integers ranging from 1 (no pain) to 8 (maximum pain) up to a maximum of 10 (paroxysmal and unbearable pain).

RESULTS AND CONCLUSIONS

The obtained results clearly demonstrate the effectiveness of bromelain in treating postoperative edema after third molar surgery.

Authors+Show Affiliations

Department of Dental Sciences and Surgery, School of Medicine, University of Bari, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

21061836

Citation

Inchingolo, F, et al. "Clinical Trial With Bromelain in Third Molar Exodontia." European Review for Medical and Pharmacological Sciences, vol. 14, no. 9, 2010, pp. 771-4.
Inchingolo F, Tatullo M, Marrelli M, et al. Clinical trial with bromelain in third molar exodontia. Eur Rev Med Pharmacol Sci. 2010;14(9):771-4.
Inchingolo, F., Tatullo, M., Marrelli, M., Inchingolo, A. M., Picciariello, V., Inchingolo, A. D., ... Cagiano, R. (2010). Clinical trial with bromelain in third molar exodontia. European Review for Medical and Pharmacological Sciences, 14(9), pp. 771-4.
Inchingolo F, et al. Clinical Trial With Bromelain in Third Molar Exodontia. Eur Rev Med Pharmacol Sci. 2010;14(9):771-4. PubMed PMID: 21061836.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical trial with bromelain in third molar exodontia. AU - Inchingolo,F, AU - Tatullo,M, AU - Marrelli,M, AU - Inchingolo,A M, AU - Picciariello,V, AU - Inchingolo,A D, AU - Dipalma,G, AU - Vermesan,D, AU - Cagiano,R, PY - 2010/11/11/entrez PY - 2010/11/11/pubmed PY - 2010/12/16/medline SP - 771 EP - 4 JF - European review for medical and pharmacological sciences JO - Eur Rev Med Pharmacol Sci VL - 14 IS - 9 N2 - BACKGROUND AND OBJECTIVE: Bromelain is a proteolytic enzyme, particularly effective in the treatment of soft tissue inflammations and traumas, in localized inflammations, especially in presence of hydropsy and also in postoperative tissue reactions. The aim of the present study is to assess the efficacy of bromelain in controlling the edema and its related pain in the inflamed area after upper third molar exodontia. MATERIALS AND METHODS: The effectiveness of our protocol was evaluated by a clinical assessment of the profile of the hemiface corresponding to the treated area: indeed, the linear values of the trago-pogonion distances were measured. Algogens were determined by VAS (Visual Analogue Scale) (Figure 1) with integers ranging from 1 (no pain) to 8 (maximum pain) up to a maximum of 10 (paroxysmal and unbearable pain). RESULTS AND CONCLUSIONS: The obtained results clearly demonstrate the effectiveness of bromelain in treating postoperative edema after third molar surgery. SN - 1128-3602 UR - https://www.unboundmedicine.com/medline/citation/21061836/Clinical_trial_with_bromelain_in_third_molar_exodontia L2 - https://medlineplus.gov/edema.html DB - PRIME DP - Unbound Medicine ER -